All data are based on the daily closing price as of December 3, 2024
s

Savior Lifetec Corp.

4167.TWO
0.67 USD
0.00
0.00%

Overview

Last close
0.67 usd
Market cap
212.18M usd
52 week high
0.80 usd
52 week low
0.53 usd
Target price
N/A usd

Valuation

P/E
58.2432
Forward P/E
N/A
Price/Sales
5.6383
Price/Book Value
1.9961
Enterprise Value
170.98M usd
EV/Revenue
4.544
EV/EBITDA
19.8096

Key financials

Revenue TTM
37.63M usd
Gross Profit TTM
4.06M usd
EBITDA TTM
6.05M usd
Earnings per Share
0.01 usd
Dividend
N/A
Total assets
3.90B usd
Net debt
-1.03B usd

About

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various products, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.
  • Symbol
    4167.TWO
  • Exchange
    TWO
  • Isin
    TW0004167002
  • Country
    Taiwan
  • Sector
    Healthcare
  • Industry
    Biotechnology
  • CEO
  • Headquarter
    Miaoli
  • Web site
    https://www.saviorlifetec.com.tw/en/
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top